NDC properties for "tetracycline (as tetracycline hydrochloride) 500 MG Oral Capsule" (RxCUI 198252)
About this data
The tables show NDC propoerties for tetracycline (as tetracycline hydrochloride) 500 MG Oral Capsule with the RxCUI 198252
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for tetracycline (as tetracycline hydrochloride) 500 MG Oral Capsule (RxCUI 198252)
| ANDA | ANDA060704 |
|---|---|
| ANDA | ANDA061837 |
| ANDA | ANDA062752 |
| ANDA | ANDA210662 |
| ANDA | ANDA210674 |
| ANDA | ANDA212635 |
| MMSL_CODE | BD3025 |
| MMSL_CODE | CD3025 |
| NDA | NDA050278 |
| RxCUI | 198252 |
| SNOMEDCT | 375874002 |
| SPL_SET_ID | 00acf413-c5d2-4a54-9d0d-56266cbc9edc |
| SPL_SET_ID | 0c809fa5-c630-4bf1-a0fc-5ee875008807 |
| SPL_SET_ID | 13a23307-61e4-4094-9132-68e38d200d18 |
| SPL_SET_ID | 22208459-3e6f-46a7-9f7f-f2c254a38132 |
| SPL_SET_ID | 2854d3b7-f874-4c67-8014-adda9639f515 |
| SPL_SET_ID | 2c9208db-5f4f-4382-854f-6786b1e458db |
| SPL_SET_ID | 32a409a0-fea6-411a-8218-c1c7df46d664 |
| SPL_SET_ID | 3ce3e8dc-7fbd-4f8d-a65f-092e1ef21725 |
| SPL_SET_ID | 5419f5dd-bf20-4eea-982d-33511a022c38 |
| SPL_SET_ID | 54d1720d-edfc-4eb4-8388-f61bd5971336 |
| SPL_SET_ID | aa30113f-ab58-4f41-82c1-2fcb540d4a82 |
| SPL_SET_ID | ae29aa18-6efb-47c9-bbd7-cbe8af1b7f38 |
| SPL_SET_ID | b45cee2a-8d11-4fda-b8f8-e1f71abf87c6 |
| SPL_SET_ID | b504e612-5aef-47fa-8f7b-dfb754011b9f |
| SPL_SET_ID | d07410b3-37e6-4382-97de-0c2676bc1103 |
| SPL_SET_ID | eaa5b1bd-0927-46e4-b941-32fcc492d258 |
| SPL_SET_ID | eb651905-007d-4a56-b010-db4a4f7c405d |
| SPL_SET_ID | edf54a38-41a7-42ec-a05f-46ab20cb6fc3 |
| SPL_SET_ID | fb338af1-2b1b-413f-9653-10f318dbc4b3 |
| VUID | 4001910 |
| Prescribable Synonym | tetracycline HCl 500 MG Oral Capsule |
| RXNAV_STR | tetracycline hydrochloride 500 MG Oral Capsule |
| RxNorm Name | tetracycline hydrochloride 500 MG Oral Capsule |
| RxNorm Synonym | tetracycline (as tetracycline hydrochloride) 500 MG Oral Capsule |
| RxNorm Synonym | tetracycline HCl 500 MG Oral Capsule |
| Related queries | Interactions (for RxCUI 198252) |
NDC Properties
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 60219152301
| NDC 9 | 60219-1523 |
|---|---|
| NDC 10 | 60219-1523-1 |
| NDC Item | 60219152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (60219-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 758551 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-08-10 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 60219-1523 |
NDC Item 62135026601
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-01 |
| NDC Item | 62135026601 |
| Packaging | 100 CAPSULE in 1 BOTTLE (62135-266-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026605
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-05 |
| NDC Item | 62135026605 |
| Packaging | 500 CAPSULE in 1 BOTTLE (62135-266-05) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026620
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-20 |
| NDC Item | 62135026620 |
| Packaging | 20 CAPSULE in 1 BOTTLE (62135-266-20) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 62135026660
| NDC 9 | 62135-266 |
|---|---|
| NDC 10 | 62135-266-60 |
| NDC Item | 62135026660 |
| Packaging | 60 CAPSULE in 1 BOTTLE (62135-266-60) |
| ANDA | ANDA062752 |
| COLORTEXT | orange,yellow |
| Color | C48331;C48330 __ |
| FDA SPL set id | 719885 |
| Imprint code | 5266 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1988-08-12 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 62135-266 |
NDC Item 64380089106
| NDC 9 | 64380-891 |
|---|---|
| NDC 10 | 64380-891-06 |
| NDC Item | 64380089106 |
| Packaging | 100 CAPSULE in 1 BOTTLE (64380-891-06) |
| ANDA | ANDA212635 |
| COLORTEXT | BLUE(Light blue Opaque Cap),YELLOW(Opaque Body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 706992 |
| Imprint code | TK;02 |
| Labeler | Strides Pharma Science Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-04-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 21 mm |
| Related queries | Properties for NDC 9 64380-891 |
NDC Item 66267020114
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-14 |
| NDC Item | 66267020114 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020120
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-20 |
| NDC Item | 66267020120 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020128
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-28 |
| NDC Item | 66267020128 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 66267020140
| NDC 9 | 66267-201 |
|---|---|
| NDC 10 | 66267-201-40 |
| NDC Item | 66267020140 |
| Related queries | Properties for NDC 9 66267-201 |
NDC Item 67405066110
| NDC 9 | 67405-661 |
|---|---|
| NDC 10 | 67405-661-10 |
| NDC Item | 67405066110 |
| Packaging | 100 CAPSULE in 1 BOTTLE (67405-661-10) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE,YELLOW |
| Color | C48331;C48330 __ |
| FDA SPL set id | 378027 |
| Imprint code | 5266 |
| Labeler | Harris Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2020-01-31 |
| Marketing effective time low | 1988-08-12 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 67405-661 |
NDC Item 69238152301
| NDC 9 | 69238-1523 |
|---|---|
| NDC 10 | 69238-1523-1 |
| NDC Item | 69238152301 |
| Packaging | 100 CAPSULE in 1 BOTTLE (69238-1523-1) |
| ANDA | ANDA210674 |
| COLORTEXT | blue(light blue opaque cap),yellow(yellow opaque body) |
| Color | C48333;C48330 __ |
| FDA SPL set id | 759174 |
| Imprint code | AMNEAL;1523 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2018-09-21 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 69238-1523 |
NDC Item 71335214101
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-1 |
| NDC Item | 71335214101 |
| Packaging | 60 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-1) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214102
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-2 |
| NDC Item | 71335214102 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-2) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214103
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-3 |
| NDC Item | 71335214103 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-3) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214104
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-4 |
| NDC Item | 71335214104 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-4) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214105
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-5 |
| NDC Item | 71335214105 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-5) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214106
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-6 |
| NDC Item | 71335214106 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-6) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214107
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-7 |
| NDC Item | 71335214107 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-7) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335214108
| NDC 9 | 71335-2141 |
|---|---|
| NDC 10 | 71335-2141-8 |
| NDC Item | 71335214108 |
| Packaging | 45 CAPSULE in 1 BOTTLE, PLASTIC (71335-2141-8) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 781939 |
| Imprint code | B907 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2141 |
NDC Item 71335242701
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-1 |
| NDC Item | 71335242701 |
| Packaging | 60 CAPSULE in 1 BOTTLE (71335-2427-1) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242702
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-2 |
| NDC Item | 71335242702 |
| Packaging | 40 CAPSULE in 1 BOTTLE (71335-2427-2) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242703
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-3 |
| NDC Item | 71335242703 |
| Packaging | 30 CAPSULE in 1 BOTTLE (71335-2427-3) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242704
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-4 |
| NDC Item | 71335242704 |
| Packaging | 56 CAPSULE in 1 BOTTLE (71335-2427-4) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242705
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-5 |
| NDC Item | 71335242705 |
| Packaging | 28 CAPSULE in 1 BOTTLE (71335-2427-5) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242706
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-6 |
| NDC Item | 71335242706 |
| Packaging | 20 CAPSULE in 1 BOTTLE (71335-2427-6) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242707
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-7 |
| NDC Item | 71335242707 |
| Packaging | 90 CAPSULE in 1 BOTTLE (71335-2427-7) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 71335242708
| NDC 9 | 71335-2427 |
|---|---|
| NDC 10 | 71335-2427-8 |
| NDC Item | 71335242708 |
| Packaging | 45 CAPSULE in 1 BOTTLE (71335-2427-8) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 795541 |
| Imprint code | 5266 |
| Labeler | Bryant Ranch Prepack |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | active |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 71335-2427 |
NDC Item 00591247501
| NDC 9 | 0591-2475 |
|---|---|
| NDC 10 | 0591-2475-01 |
| NDC Item | 00591247501 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (0591-2475-01) |
| ANDA | ANDA061837 |
| COLORTEXT | black(Black Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48323;C48330 __ |
| FDA SPL set id | 558144 |
| Imprint code | WPI;2235 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2011-08-15 |
| Marketing status | DROPPED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 0591-2475 |
NDC Item 10544059028
| NDC 9 | 10544-590 |
|---|---|
| NDC 10 | 10544-590-28 |
| NDC Item | 10544059028 |
| Packaging | 28 CAPSULE in 1 BOTTLE (10544-590-28) |
| ANDA | ANDA060704 |
| COLORTEXT | black,yellow |
| Color | C48323;C48330 __ |
| FDA SPL set id | 17532 |
| Imprint code | 2407 |
| Labeler | Blenheim Pharmacal, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-03 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 10544-590 |
NDC Item 23155001801
| NDC 9 | 23155-018 |
|---|---|
| NDC 10 | 23155-018-01 |
| NDC Item | 23155001801 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-018-01) |
| COLORTEXT | YELLOW(body),BLUE(cap) |
| Color | C48330;C48333 __ |
| FDA SPL set id | 524549 |
| Imprint code | HP;18 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2024-09-15 |
| Marketing status | COMPLETED |
| NDA | NDA050278 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-018 |
NDC Item 23155076701
| NDC 9 | 23155-767 |
|---|---|
| NDC 10 | 23155-767-01 |
| NDC Item | 23155076701 |
| Packaging | 100 CAPSULE in 1 BOTTLE (23155-767-01) |
| ANDA | ANDA062752 |
| COLORTEXT | orange(Orange Opaque Cap),yellow(Yellow Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 717683 |
| Imprint code | 5266 |
| Labeler | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-04-01 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 23155-767 |
NDC Item 47781050901
| NDC 9 | 47781-509 |
|---|---|
| NDC 10 | 47781-509-01 |
| NDC Item | 47781050901 |
| Packaging | 100 CAPSULE in 1 BOTTLE (47781-509-01) |
| ANDA | ANDA062752 |
| COLORTEXT | ORANGE(Opaque Cap),YELLOW(Opaque Body) |
| Color | C48331;C48330 __ |
| FDA SPL set id | 406382 |
| Imprint code | 5266 |
| Labeler | Alvogen, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2022-04-01 |
| Marketing effective time low | 2016-12-19 |
| Marketing status | COMPLETED |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 47781-509 |
NDC Item 51991090701
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-01 |
| NDC Item | 51991090701 |
| Packaging | 100 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-01) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090705
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-05 |
| NDC Item | 51991090705 |
| Packaging | 500 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-05) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 51991090733
| NDC 9 | 51991-907 |
|---|---|
| NDC 10 | 51991-907-33 |
| NDC Item | 51991090733 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (51991-907-33) |
| ANDA | ANDA210662 |
| COLORTEXT | BLUE |
| Color | C48333 __ |
| FDA SPL set id | 777555 |
| Imprint code | B907 |
| Labeler | Breckenridge Pharmaceutical, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2019-01-18 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 51991-907 |
NDC Item 52959033614
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-14 |
| NDC Item | 52959033614 |
| Packaging | 14 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-14) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033620
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-20 |
| NDC Item | 52959033620 |
| Packaging | 20 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-20) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033628
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-28 |
| NDC Item | 52959033628 |
| Packaging | 28 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-28) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033630
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-30 |
| NDC Item | 52959033630 |
| Packaging | 30 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-30) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033640
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-40 |
| NDC Item | 52959033640 |
| Packaging | 40 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-40) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033656
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-56 |
| NDC Item | 52959033656 |
| Packaging | 56 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-56) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-03-23 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 52959-336 |
NDC Item 52959033690
| NDC 9 | 52959-336 |
|---|---|
| NDC 10 | 52959-336-90 |
| NDC Item | 52959033690 |
| Packaging | 90 CAPSULE in 1 BOTTLE, PLASTIC (52959-336-90) |
| ANDA | ANDA060704 |
| COLORTEXT | BLACK,YELLOW |
| Color | C48323;C48330 __ |
| FDA SPL set id | 75103 |
| Imprint code | Z;2407 |
| Labeler | H.J. Harkins Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Ma |